Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Structural Imaging

Dementia TodayPublished June 25, 20117 min read
An important advance in the evaluation of people with suspected dementia of the Alzheimer type is the use of structural imaging to assess in vivo neuroanatomical changes. This technique can also be used in conjunction with neuropsychological test data to better understand the relationship between the structural brain changes and the cognitive deficits that characterize the disease.

Key points

  • An important advance in the evaluation of people with suspected dementia of the Alzheimer type is the use of structural imaging to assess in vivo neuroanatomical changes.
  • Integrity of the hippocampus has been strongly implicated in episodic memory (Squire 1992).
  • Recent evidence strongly suggests that one of the earliest changes in dementia of the Alzheimer type is neurofibrillary tangles in the entorhinal cortex (Braak, Braak, and Bohl 1993).
  • Other investigators have demonstrated the importance of measuring whole brain volume (Fox and Rossor 1999; Fox, Warrington, and Rossor 1999) to differentiate dementia of the Alzheimer type from healthy controls.

An important advance in the evaluation of people with suspected dementia of the Alzheimer type is the use of structural imaging to assess in vivo neuroanatomical changes. This technique can also be used in conjunction with neuropsychological test data to better understand the relationship between the structural brain changes and the cognitive deficits that characterize the disease.

Hippocampus

Integrity of the hippocampus has been strongly implicated in episodic memory (Squire 1992). Magnetic resonance imaging studies indicate substantial hippocampal atrophy in DAT, even in the very early stages of the disease (Jack et al. 1992; Scheltens et al. 1992; Killiany et al. 1993; Laakso et al. 1995; Johnson et al. 1998). In contrast, the hippocampus is spared significant aging effects through the seventh decade of life in healthy normals (Bigler et al. 1997). Studies of hippocampal atrophy in patients and healthy controls have reported agerelated volume changes (i.e., greater volume loss with increased age) only in healthy controls. In contrast, in persons with MCI and DAT, volume reductions were not related to age (de Leon et al. 1997; de Toledo-Morrell et al. 1997). Although minimal longitudinal data are available, Jack, Petersen, and Xu (1998, 2000) reported significant annual decline in hippocampal volume in healthy older adults; persons with MCI showed somewhat greater rates of decline, while persons with DAT showed the greatest decline. Furthermore, within the control and MCI groups, clinical decline was related to greater rates of hippocampal atrophy.

Several studies have examined the relationship between hippocampal volume and cognitive functioning.

For example, de Leon et al. (1997) found that after controlling for age, education, and immediate memory, a significant correlation was found between delayed memory and hippocampal atrophy in normal controls, but not in individuals with MCI (subjects with DAT were too impaired to be studied). In contrast, Convit et al. (1997) reported a relationship between delayed memory function and hippocampal volume in both healthy controls and persons with MCI. This may reflect the degree of impairment in the population with MCI in the de Leon study, since these relations become harder to detect as cognitive impairment becomes more severe. General cognitive measures such as the MMSE did not distinguish between normal controls and participants with MCI, and had no relationship to hippocampal volume. This lack of association has also been reported in persons with DAT (de Toledo-Morrell et al. 1997). Wilson et al. (1996) reported that hippocampal formation volume was associated with a delayed recall measure, but not with immediate recall, and with an object-naming test in persons with DAT. Medial temporal region volumes have been found to be correlated with delayed memory performance in persons with DAT (Kohler et al. 1998) and in elderly individuals without dementia (Golomb et al. 1994; Convit et al. 1997).

  1. Normal Aging & Dementia
  2. Concepts and Criteria
  3. Normal Aging
  4. Age-associated Memory Impairment
  5. Age-associated Cognitive Decline
  6. Mild Cognitive Impairment
  7. Diagnose dementia
  8. Cognition and Cognitive Testing
  9. Memory Impairment
  10. Executive Ability
  11. Visuospatial/Constructional and Visuoperceptual Abilities
  12. Praxis
  13. Neuroanatomy
  14. Structural Imaging
  15. Hippocampus
  16. Entorhinal Cortex
  17. Other Structural Changes
  18. Functional Imaging
  19. Functional Activation Studies
  20. Clinical Conclusions
  21. Acknowledgments

Entorhinal Cortex

Recent evidence strongly suggests that one of the earliest changes in dementia of the Alzheimer type is neurofibrillary tangles in the entorhinal cortex (Braak, Braak, and Bohl 1993). Measurement of the entorhinal cortex may provide a useful marker for early diagnosis (Bobinski et al. 1999). MRI studies show significant reductions of entorhinal cortex volume in DAT (Pearlson et al. 1992; Desmond et al. 1994; Juottonen et al. 1998; Krasuski et al. 1998). Entorhinal cortex volume is reduced even in persons with MCI compared to controls on MRI (Xu et al. 2000) and postmortem evaluation (Kordower et al. 2001). Baseline volumes of the entorhinal cortex predict conversion from MCI to DAT (Fox et al. 1996; Jack et al. 1999; Killiany et al. 2000). Juottonen et al. (1998) reported a significant correlation between left entorhinal cortex volume (corrected for whole brain size) and MMSE scores in persons with DAT.

Other Structural Changes

Other investigators have demonstrated the importance of measuring whole brain volume (Fox and Rossor 1999; Fox, Warrington, and Rossor 1999) to differentiate dementia of the Alzheimer type from healthy controls. White matter lesions (Barber et al. 1999; Wolf et al. 2000; DeCarli et al. 2001; Farkas and Luiten 2001) and metabolite changes (for review, Valenzuela and Sachdev 2001) may also be helpful for distinguishing between healthy controls and individuals with MCI and DAT. These measures may prove to be useful early indicators of conversion from MCI to DAT.

In summary, quantitative structural neuroimaging has revealed prominent and progressive cortical atrophy in dementia of the Alzheimer type starting in the earliest stages of the disease, with particular involvement of mesial temporal structures including entorhinal cortex and hippocampus observed even in mild cognitive impairment. In clinical practice, detailed evaluation of MRI findings in very mild cases may be of particular interest for early diagnosis (Soininen et al. 1994; Parnetti et al. 1996; Convit et al. 1997, 2000; de Toledo-Morrell et al. 1997; Jack et al. 1997). A promising new direction in structural neuroimaging of MCI and DAT is voxel-based morphometry (Ashburner and Friston 2000; Chung et al. 2001), a technique involving analysis of white matter, and cerebrospinal fluid tissue compartments on a voxel-by-voxel basis. Voxel-based morphometry may increase the clinical applicability of volumetric assessment in the early detection of at-risk individuals and those with early stages of dementia. Other promising techniques include functional neuroimaging methods.

###

Laura A. Flashman, Ph.D.,
Heather A. Wishart, Ph.D.,
Thomas E. Oxman, M.D.,
and Andrew J. Saykin, Psy.D.

###

REFERENCES

  1. Kral, V.A. 1958. Neuro-psychiatric observations in an old peoples home. Journal of Gerontology 13:169-76.
  2. Kral, V.A. 1962. Senescent forgetfulness: Benign and malignant. Canadian Medical Association Journal 86:257-60.
  3. Krasuski, J.S., G.E. Alexander, B. Horwitz, et al. 1998. Volumes of medial temporal lobe structures in patients with Alzheimer’s disease and mild cognitive impairment (and in healthy controls). Biological Psychiatry 43 (1):60-68.
  4. Kuhl, D.E., R.A. Koeppe, S. Minoshima, et al. 1999. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease. Neurology 52:691-99.
  5. Laakso, M.P., H. Soininen, K. Partanen, et al. 1995. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer’s disease: correlation with memory functions. Journal of Neural Transmission, Parkinson Disease and Dementia Section 9 (1):73-86.
  6. Lange, K.W., B.J. Sahakian, N.P. Quinn, et al. 1995. Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia. Journal of Neurology, Neurosurgery, and Psychiatry 58 (5):598-606.
  7. Lauter, H. 1985. What do we know about Alzheimer’s disease today? Danish Medical Bulletin 32 (Suppl. 1):S1-21.

Full References »

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Tracking down the causes of Alzheimer’s
Aging & Dementia

Tracking down the causes of Alzheimer’s

Genes are not only important for regular memory performance, but also for the development of Alzheimer’s disease. Researchers at the University of Basel now identified a specific group of genes that plays a central role in both processes. This group

3 min read

Accuracy of dementia brain imaging must improve
Aging & Dementia

Accuracy of dementia brain imaging must improve

MRI scans and other tools to detect and diagnose dementia are helpful but not definitive – according to new research from the University of East Anglia. A report published today in The Lancet Neurology evaluates for the first time how

4 min read

The power of music to help dementia patients
Aging & Dementia

The power of music to help dementia patients

Describing his recently published research, Dr. Martin Hirsch – from Queen Mary, University of London – said: “We have known since the time of Florence Nightingale that music has a positive impact on patients during surgery, by making them feel

5 min read

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.